Reversal of apparent premature ovarian failure in a patient with myasthenia gravis.
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy / Q000209:etiology*; D009157:Myasthenia Gravis / Q000150:complications* / Q000628:therapy; D010049:Ovarian Diseases / Q000150:complications* / Q000188:drug therapy; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D004966:Estrogens, Conjugated (USP); D011729:Pyridostigmine Bromide; D001379:Azathioprine; D011241:Prednisone